Drug discontinuation: Gadobutrol Injection (GADOBUTROL)
FDA lists 4 presentations as To Be Discontinued. Companies: Jiangsu Hengrui Pharmaceuticals Co., Ltd..
- Published by source
- 2026-06-30
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Products
- Gadobutrol Injection GADOBUTROL
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-06-30
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #884 | new | 2026-10-22 | c730f4fc4732…9c44f0 | b47227d8b903…184383 |
Chain head: #1094 edf3be25ec2e…478842